Truist Financial’s Takeda Pharmaceutical TAK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.01M Sell
65,137
-1,537
-2% -$23.8K ﹤0.01% 1584
2025
Q1
$991K Sell
66,674
-3,257
-5% -$48.4K ﹤0.01% 1512
2024
Q4
$926K Sell
69,931
-14,525
-17% -$192K ﹤0.01% 1577
2024
Q3
$1.2M Sell
84,456
-43,432
-34% -$618K ﹤0.01% 1433
2024
Q2
$1.65M Sell
127,888
-6,998
-5% -$90.6K ﹤0.01% 1351
2024
Q1
$1.87M Sell
134,886
-72,933
-35% -$1.01M ﹤0.01% 1306
2023
Q4
$2.97M Sell
207,819
-36,574
-15% -$522K ﹤0.01% 1068
2023
Q3
$3.78M Sell
244,393
-5,645
-2% -$87.3K 0.01% 946
2023
Q2
$3.93M Buy
250,038
+9,955
+4% +$156K 0.01% 927
2023
Q1
$3.96M Buy
240,083
+73,984
+45% +$1.22M 0.01% 917
2022
Q4
$2.59M Buy
166,099
+87,266
+111% +$1.36M ﹤0.01% 1077
2022
Q3
$1.02M Sell
78,833
-6,522
-8% -$84.6K ﹤0.01% 1480
2022
Q2
$1.2M Buy
85,355
+4,824
+6% +$67.8K ﹤0.01% 1449
2022
Q1
$1.15M Sell
80,531
-2,438
-3% -$34.9K ﹤0.01% 1559
2021
Q4
$1.13M Sell
82,969
-10,577
-11% -$144K ﹤0.01% 1554
2021
Q3
$1.53M Sell
93,546
-2,065
-2% -$33.8K ﹤0.01% 1391
2021
Q2
$1.61M Buy
95,611
+22,855
+31% +$385K ﹤0.01% 1399
2021
Q1
$1.33M Sell
72,756
-11,597
-14% -$212K ﹤0.01% 1415
2020
Q4
$1.54M Sell
84,353
-13,541
-14% -$246K ﹤0.01% 1287
2020
Q3
$1.75M Sell
97,894
-20,528
-17% -$366K ﹤0.01% 1121
2020
Q2
$2.12M Sell
118,422
-17,161
-13% -$308K ﹤0.01% 999
2020
Q1
$2.06M Sell
135,583
-16,468
-11% -$250K 0.01% 967
2019
Q4
$3M Buy
152,051
+40,637
+36% +$802K 0.01% 956
2019
Q3
$1.92M Buy
111,414
+5,398
+5% +$92.9K 0.03% 363
2019
Q2
$1.88M Buy
106,016
+14,563
+16% +$258K 0.03% 365
2019
Q1
$1.86M Buy
91,453
+29,105
+47% +$593K 0.03% 361
2018
Q4
$1.05M Buy
+62,348
New +$1.05M 0.02% 441